title: Administration of selegiline is not associated with visual hallucinations in advanced Parkinson's disease patients.
authors.forename: S
authors.initials: S
authors.lastname: Papapetropoulos
authors.forename: A A
authors.initials: AA
authors.lastname: Argyriou
mesh_terms: D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000009:adverse effects; D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000008:administration & dosage* / Q000009:adverse effects
chemical_list: D000978:Antiparkinson Agents; D012642:Selegiline